Delivery Order SPE2DB20D1109-SPE2DB24FN32X
Award Date 12/27/23
Potential Completion Date 12/28/23
Potential Value $5.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of 4564448773 CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA). The $2,962.24 firm fixed-price delivery order contract, awarded on April 30, 2024, has an ultimate completion date of May 1, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $14,505.87 for the pharmaceutical product Contrave ER 8-90 mg Tablets. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has an ultimate completion date of March 25, 2024. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,119.94 firm fixed-price delivery order is for the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. The award has an ultimate completion date of February 8, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $28,946.20 firm-fixed-price delivery order is for CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The award has an ultimate completion date of November 7, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,657.26 delivery order contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract is a firm fixed-price type with a completion date of February 13, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The total ceiling value of the contract is $4,604.61, with a completion date of October 25, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $3,585.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Contrave ER 8-90 mg tablets, a pharmaceutical product, to support military healthcare programs. The award has an ultimate completion date of April 26, 2024 and is structured as a firm-fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,316.73, is a delivery order for the product "CONTRAVE ER 8-90 MG TABLET 120S". The award has an ultimate completion date of December 28, 2023 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $28,520.58 firm-fixed-price contract covers the delivery of 120 count bottles of the pharmaceutical product CONTRAVE ER 8-90 MG TABLET. The contract has an ultimate completion date of December 20, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,011.33 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of CONTRAVE ER 8-90 MG TABLET 120S medication to support military healthcare programs. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...